Successful treatment of refractory cold agglutinin syndrome using fixed duration daratumumab, bortezomib and dexamethasone with a sutimlimab bridge
Authors
- Brad Rybinski (ORCID: https://orcid.org/0000-0002-3180-4496)
- Rima Koka (ORCID: https://orcid.org/0000-0002-0457-8489)
- Nancy M. Hardy (ORCID: https://orcid.org/0000-0002-6054-6836)
- Aaron P. Rapoport (ORCID: https://orcid.org/0000-0003-0043-3562)
- Martin James (ORCID: https://orcid.org/0000-0001-6065-6018)
Institutions
- University of Maryland, Baltimore (US)
- University of Maryland Medical Center (US)
- University of Baltimore (US)